AIG
JBIO

American International Group’s Jade Biosciences JBIO Stock Holding History

American International Group’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-157
Closed -$163K – 265
2024
Q1 		$163K Sell
157
-2
-1% -$1.53K ﹤0.01% 2265
2023
Q4 		$126K Hold
159
– – ﹤0.01% 2430
2023
Q3 		$75.7K Buy
159
+21
+15% +$11.4K ﹤0.01% 2664
2023
Q2 		$83.1K Buy
138
+11
+9% +$7.04K ﹤0.01% 2697
2023
Q1 		$89.4K Buy
127
+3
+2% +$2.49K ﹤0.01% 2511
2022
Q4 		$127K Sell
124
-1
-0.8% -$726 ﹤0.01% 2395
2022
Q3 		$72K Buy
125
+2
+2% +$1.33K ﹤0.01% 2695
2022
Q2 		$67K Sell
123
-63
-34% -$30.1K ﹤0.01% 2771
2022
Q1 		$119K Buy
186
+33
+22% +$12.8K ﹤0.01% 2520
2021
Q4 		$63K Sell
153
-5
-3% -$2.53K ﹤0.01% 2885
2021
Q3 		$116K Buy
+158
New +$88.5K ﹤0.01% 2736

Other funds holding JBIO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

American International Group's JBIO Position: Q2 2024 in Review

American International Group sold out of Jade Biosciences (JBIO) in Q2 2024, closing a stake of 157 shares — an estimated $163K sold.

American International Group first reported a position in JBIO in Q3 2021 and held it in 11 quarters. The position peaked at $163K in Q1 2024. 80 funds tracked by Wall St. Rank hold JBIO as of Q2 2024.

  • American International Group reported no remaining Jade Biosciences position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 157 Jade Biosciences shares in Q2 2024, an estimated $163K.
  • American International Group first reported a position in Jade Biosciences in Q3 2021 and held it in 11 quarters.
  • American International Group's Jade Biosciences position peaked at $163K in Q1 2024.
  • 80 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.